Additionally, Jiang et al. [37] reported that tumor-associated p53 mutants lack G6PD inhibitory activity and that the enhanced PPP glucose flux due to the activation of p53 may increase the glucose consumption and direct glucose to biosynthesis in tumor cells. This evidence concerns the gene G6PD and neoplasm.